Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Jun 26

PMID 32582221

Citations 14

Authors

Muhammad Abbas Abid

Loren Nunley

Muhammad Bilal Abid

Affiliations

Soon will be listed here.

Citing Articles

Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing.

Mankowska-Wierzbicka D, Zuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A Biomedicines. 2023; 11(2).

PMID: 36830905 PMC: 9953267. DOI: 10.3390/biomedicines11020367.

SARS-CoV-2 Variants, Vaccines, and Host Immunity.

Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen I Front Immunol. 2022; 12:809244.

PMID: 35046961 PMC: 8761766. DOI: 10.3389/fimmu.2021.809244.

Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.

Hussain I, Cher G, Abid M, Abid M Front Immunol. 2021; 12:765965.

PMID: 34721437 PMC: 8551858. DOI: 10.3389/fimmu.2021.765965.

Is COVID-19 impacting cancer screening in Pakistan? An observational study of cancer screening test requests during the pandemic.

Ahmed D, Abbas Abid D, Niaz Ali M, Ahmed M, Siddiqui D Ann Med Surg (Lond). 2021; 71:102934.

PMID: 34659748 PMC: 8511888. DOI: 10.1016/j.amsu.2021.102934.

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses.

Meir J, Abid M, Abid M Transplant Cell Ther. 2021; 27(12):973-987.

PMID: 34587552 PMC: 8473073. DOI: 10.1016/j.jtct.2021.09.016.

References

Guzman M, Alvarez M, Halstead S . Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013; 158(7):1445-59. DOI: 10.1007/s00705-013-1645-3. View

Koutsakos M, Wheatley A, Loh L, Clemens E, Sant S, Nussing S . Circulating T cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018; 10(428). DOI: 10.1126/scitranslmed.aan8405. View

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Gautret P, Lagier J, Parola P, Hoang V, Meddeb L, Mailhe M . RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. PMC: 7102549. DOI: 10.1016/j.ijantimicag.2020.105949. View

Zhao J, Zhao J, Mangalam A, Channappanavar R, Fett C, Meyerholz D . Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. Immunity. 2016; 44(6):1379-91. PMC: 4917442. DOI: 10.1016/j.immuni.2016.05.006. View

Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

Kissler S, Tedijanto C, Goldstein E, Grad Y, Lipsitch M . Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020; 368(6493):860-868. PMC: 7164482. DOI: 10.1126/science.abb5793. View

Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

10.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

11.

Li G, Chen X, Xu A . Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003; 349(5):508-9. DOI: 10.1056/NEJM200307313490520. View

12.

Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S . Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020; 14(2):125-128. DOI: 10.3855/jidc.12600. View

13.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

14.

Tang F, Quan Y, Xin Z, Wrammert J, Ma M, Lv H . Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011; 186(12):7264-8. DOI: 10.4049/jimmunol.0903490. View

15.

Thevarajan I, Nguyen T, Koutsakos M, Druce J, Caly L, van de Sandt C . Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020; 26(4):453-455. PMC: 7095036. DOI: 10.1038/s41591-020-0819-2. View

16.

McElroy A, Akondy R, Davis C, Ellebedy A, Mehta A, Kraft C . Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A. 2015; 112(15):4719-24. PMC: 4403189. DOI: 10.1073/pnas.1502619112. View

17.

Paul L, Carlin E, Jenkins M, Tan A, Barcellona C, Nicholson C . Dengue virus antibodies enhance Zika virus infection. Clin Transl Immunology. 2017; 5(12):e117. PMC: 5192063. DOI: 10.1038/cti.2016.72. View

18.

Huang M, Tang T, Pang P, Li M, Ma R, Lu J . Treating COVID-19 with Chloroquine. J Mol Cell Biol. 2020; 12(4):322-325. PMC: 7232130. DOI: 10.1093/jmcb/mjaa014. View

19.

Iwasaki A, Yang Y . The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol. 2020; 20(6):339-341. PMC: 7187142. DOI: 10.1038/s41577-020-0321-6. View

20.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3):335-337. PMC: 7159000. DOI: 10.1016/S1470-2045(20)30096-6. View